Chongqing, China

Tao Cheng

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Fochon Pharmaceuticals, Ltd., Loncin Industry Co., Ltd.. Active years: 2010-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tao Cheng. Retrieved from https://idiyas.com/inventor/tao-cheng-tvi83b49

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2010-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Tao Cheng - Revolutionizing Technology in Chongqing

Introduction: Tao Cheng is a visionary inventor based in Chongqing, China, known for his groundbreaking contributions to the field of technology.

Latest Patents: Tao Cheng holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Tao Cheng has worked with leading tech companies in China, spearheading research and development projects that have led to significant advancements in various industries.

Collaborations: Throughout his career, Tao Cheng has collaborated with top researchers, engineers, and scientists both locally and internationally, fostering a culture of innovation and knowledge exchange.

Conclusion: Inventor Tao Cheng's relentless pursuit of innovation and his passion for pushing the boundaries of technology continue to inspire the next generation of inventors and entrepreneurs in Chongqing and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…